458 related articles for article (PubMed ID: 28493126)
1. Application of CRISPR/Cas9 Genome Editing to Improve Recombinant Protein Production in CHO Cells.
Grav LM; la Cour Karottki KJ; Lee JS; Kildegaard HF
Methods Mol Biol; 2017; 1603():101-118. PubMed ID: 28493126
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-mediated genome engineering of CHO cell factories: Application and perspectives.
Lee JS; Grav LM; Lewis NE; Faustrup Kildegaard H
Biotechnol J; 2015 Jul; 10(7):979-94. PubMed ID: 26058577
[TBL] [Abstract][Full Text] [Related]
3. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells.
Wang Q; Chung CY; Rosenberg JN; Yu G; Betenbaugh MJ
Methods Mol Biol; 2018; 1850():237-257. PubMed ID: 30242691
[TBL] [Abstract][Full Text] [Related]
4. Improving the efficiency of CHO cell line generation using glutamine synthetase gene knockout cells.
Fan L; Kadura I; Krebs LE; Hatfield CC; Shaw MM; Frye CC
Biotechnol Bioeng; 2012 Apr; 109(4):1007-15. PubMed ID: 22068567
[TBL] [Abstract][Full Text] [Related]
5. One-step generation of triple knockout CHO cell lines using CRISPR/Cas9 and fluorescent enrichment.
Grav LM; Lee JS; Gerling S; Kallehauge TB; Hansen AH; Kol S; Lee GM; Pedersen LE; Kildegaard HF
Biotechnol J; 2015 Sep; 10(9):1446-56. PubMed ID: 25864574
[TBL] [Abstract][Full Text] [Related]
6. CRISPR/Cas9 as a Genome Editing Tool for Targeted Gene Integration in CHO Cells.
Sergeeva D; Camacho-Zaragoza JM; Lee JS; Kildegaard HF
Methods Mol Biol; 2019; 1961():213-232. PubMed ID: 30912048
[TBL] [Abstract][Full Text] [Related]
7. Improvement of the efficiency and quality in developing a new CHO host cell line.
Huhn SC; Ou Y; Tang X; Jiang B; Liu R; Lin H; Du Z
Biotechnol Prog; 2021 Sep; 37(5):e3185. PubMed ID: 34142466
[TBL] [Abstract][Full Text] [Related]
8. High throughput, efficacious gene editing & genome surveillance in Chinese hamster ovary cells.
Huhn SC; Ou Y; Kumar A; Liu R; Du Z
PLoS One; 2019; 14(12):e0218653. PubMed ID: 31856197
[TBL] [Abstract][Full Text] [Related]
9. Accelerating genome editing in CHO cells using CRISPR Cas9 and CRISPy, a web-based target finding tool.
Ronda C; Pedersen LE; Hansen HG; Kallehauge TB; Betenbaugh MJ; Nielsen AT; Kildegaard HF
Biotechnol Bioeng; 2014 Aug; 111(8):1604-16. PubMed ID: 24827782
[TBL] [Abstract][Full Text] [Related]
10. Enhanced Genome Editing Tools For Multi-Gene Deletion Knock-Out Approaches Using Paired CRISPR sgRNAs in CHO Cells.
Schmieder V; Bydlinski N; Strasser R; Baumann M; Kildegaard HF; Jadhav V; Borth N
Biotechnol J; 2018 Mar; 13(3):e1700211. PubMed ID: 28976642
[TBL] [Abstract][Full Text] [Related]
11. Development of a highly-efficient CHO cell line generation system with engineered SV40E promoter.
Fan L; Kadura I; Krebs LE; Larson JL; Bowden DM; Frye CC
J Biotechnol; 2013 Dec; 168(4):652-8. PubMed ID: 23994266
[TBL] [Abstract][Full Text] [Related]
12. Controlling Ratios of Plasmid-Based Double Cut Donor and CRISPR/Cas9 Components to Enhance Targeted Integration of Transgenes in Chinese Hamster Ovary Cells.
Shin SW; Kim D; Lee JS
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33673701
[TBL] [Abstract][Full Text] [Related]
13. Expanding the CRISPR toolbox for Chinese hamster ovary cells with comprehensive tools for Mad7 genome editing.
Rojek JB; Basavaraju Y; Nallapareddy S; Bulté DB; Baumgartner R; Schoffelen S; Grav LM; Goletz S; Pedersen LE
Biotechnol Bioeng; 2023 Jun; 120(6):1478-1491. PubMed ID: 36864663
[TBL] [Abstract][Full Text] [Related]
14. CRISPR/Cas12a-mediated CHO genome engineering can be effectively integrated at multiple stages of the cell line generation process for bioproduction.
Schweickert PG; Wang N; Sandefur SL; Lloyd ME; Konieczny SF; Frye CC; Cheng Z
Biotechnol J; 2021 Apr; 16(4):e2000308. PubMed ID: 33369118
[TBL] [Abstract][Full Text] [Related]
15. A Site-Specific Integration Reporter System That Enables Rapid Evaluation of CRISPR/Cas9-Mediated Genome Editing Strategies in CHO Cells.
Hamaker NK; Lee KH
Biotechnol J; 2020 Aug; 15(8):e2000057. PubMed ID: 32500600
[TBL] [Abstract][Full Text] [Related]
16. CRISPR Technologies in Chinese Hamster Ovary Cell Line Engineering.
Glinšek K; Bozovičar K; Bratkovič T
Int J Mol Sci; 2023 May; 24(9):. PubMed ID: 37175850
[TBL] [Abstract][Full Text] [Related]
17. Enhanced genome editing in mammalian cells with a modified dual-fluorescent surrogate system.
Zhou Y; Liu Y; Hussmann D; Brøgger P; Al-Saaidi RA; Tan S; Lin L; Petersen TS; Zhou GQ; Bross P; Aagaard L; Klein T; Rønn SG; Pedersen HD; Bolund L; Nielsen AL; Sørensen CB; Luo Y
Cell Mol Life Sci; 2016 Jul; 73(13):2543-63. PubMed ID: 26755436
[TBL] [Abstract][Full Text] [Related]
18. Harnessing the native type I-B CRISPR-Cas for genome editing in a polyploid archaeon.
Cheng F; Gong L; Zhao D; Yang H; Zhou J; Li M; Xiang H
J Genet Genomics; 2017 Nov; 44(11):541-548. PubMed ID: 29169919
[TBL] [Abstract][Full Text] [Related]
19. CRISPR/Cas9-Mediated Knockout of MicroRNA-744 Improves Antibody Titer of CHO Production Cell Lines.
Raab N; Mathias S; Alt K; Handrick R; Fischer S; Schmieder V; Jadhav V; Borth N; Otte K
Biotechnol J; 2019 May; 14(5):e1800477. PubMed ID: 30802343
[TBL] [Abstract][Full Text] [Related]
20. Enhanced Biosynthesis Performance of Heterologous Proteins in CHO-K1 Cells Using CRISPR-Cas9.
Wang W; Zheng W; Hu F; He X; Wu D; Zhang W; Liu H; Ma X
ACS Synth Biol; 2018 May; 7(5):1259-1268. PubMed ID: 29683658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
